A quantitative study of the efficacy of a deletion mutant bovine herpesvirus-1 differential vaccine in reducing the establishment of latency by wildtype virus

By Galeota J.A.   Flores E.F.   Kit S.   Kit M.   Osorio F.A.  

Vaccine, Vol. 15, Iss. 2, 1997-02 ,pp. : 123-128

Elsevier

Access to resources Recommend Favorite

Inactivated bovine herpesvirus 1 marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine

By Bosch J.C.   Kaashoek M.J.   van Oirschot J.T.  

Vaccine, Vol. 15, Iss. 14, 1997-10 ,pp. : 1512-1517

Elsevier

Access to resources Recommend Favorite

An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation

By Kaashoek M.J.   Moerman A.   Madic J.   Weerdmeester K.   Maris-Veldhuis M.   Rijsewijk F.A.M.   van Oirschot J.T.  

Vaccine, Vol. 13, Iss. 4, 1995-01 ,pp. : 342-346

Elsevier

Access to resources Recommend Favorite

Specific passive immunity reduces the excretion of glycoprotein E-negative bovine herpesvirus type 1 vaccine strain in calves

By Lemaire M.   Hanon E.   Schynts F.   Meyer G.   Thiry E.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1013-1017

Elsevier

Access to resources Recommend Favorite

An inactivated gE-negative marker vaccine and an experimental gD-subunit vaccine reduce the incidence of bovine herpesvirus 1 infections in the field

By Bosch J.C.   De Jong M.C.M.   Franken P.   Frankena K.   Hage J.J.   Kaashoek M.J.   Maris-Veldhuis M.A.   Noordhuizen J.P.T.M.   Van der Poel W.H.M.   Verhoeff J.   Weerdmeester K.   Zimmer G.M.   Van Oirschot J.T.  

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 265-271

Elsevier

Access to resources Recommend Favorite